Neumann Advisory Hong Kong LTD Moderna, Inc. Transaction History
Neumann Advisory Hong Kong LTD
- $393 Million
- Q3 2025
A detailed history of Neumann Advisory Hong Kong LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Neumann Advisory Hong Kong LTD holds 21,285 shares of MRNA stock, worth $558,731. This represents 0.14% of its overall portfolio holdings.
Number of Shares
21,285
Previous 21,285
-0.0%
Holding current value
$558,731
Previous $587,000
6.3%
% of portfolio
0.14%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$671 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$580 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$453 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$233 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...